Loading company…
Tres Alchemix applies AI and quantum-level calculations to pharmaceutical drug research.
Tres Alchemix develops computational tools that use AI and quantum-level chemical calculations to support drug research for pharmaceutical companies and academic institutions. Founded in 2023 and based in Fukuoka-shi, Japan, it raised JPY 650 million in Series A funding in September 2025, led by DNX Ventures with WASEDA University Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in